文献速递系统性红斑狼疮其他结缔组织病

TLR7 p.Glu834*截短变异与幼年起病SLE及体外病理细胞因子表达相关

The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro.
PubMed 文献 · Ann Rheum Dis · 2026-08-22

研究对英国319例幼年起病SLE患者行TLR7编码变异靶向测序,在一名多系统受累女性患者中鉴定出既往未报道的杂合TLR7 p.Glu834*截短变异;功能研究显示该变异通过持续结合UNC93B1、与TLR8非经典二聚化,增强促炎细胞因子表达,并与患者外周血干扰素特征升高一致。

要点

  • TLR7 p.Glu834*为私密性截短变异,见于一名多系统受累的幼年起病SLE女性患者。
  • 该变异持续结合UNC93B1,促成内溶酶体整合并与TLR8非经典二聚化。
  • 体外TLR7/8刺激后促炎细胞因子表达增强,患者外周血干扰素特征升高。

核心结论

  • 私密性截短TLR7 p.Glu834*变异可能通过与TLR8偶联关联SLE样临床表型。

研究设计与样本

  • 对英国319例幼年起病SLE患者行靶向新一代测序鉴定TLR7编码变异,并对既往未报道变异开展功能研究。

主要发现

  • 在一名有多系统病变、狼疮样自身免疫家族史及过早死亡家族史的女性jSLE患者中检出杂合TLR7 p.Glu834*截短变异。
  • 该患者早产,并表现神经发育迟缓和严重神经精神受累。
  • TLR7 p.Glu834*持续与UNC93B1伴侣相互作用,允许内溶酶体整合并与TLR8非经典二聚化,TLR7/8 engagement后促炎细胞因子表达增强。
  • 患者外周血细胞干扰素特征升高,与体外观察一致。
  • 分子建模提示TLR8:TLR7 p.Glu834*异二聚体因TLR7与TLR8形状互补性可形成,且二聚体界面相互作用较内源性TLR8:TLR8二聚体更有利。

临床怎么用

  • 支持对SLE进行遗传风险分层,并考虑TLR和/或IFN靶向治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The X chromosome-linked Toll-like receptor (TLR)7 gene contributes to type I interferon (IFN) expression in systemic lupus erythematosus (SLE). Recently, ultra-rare variants in TLR7 have been linked with Mendelian forms of SLE. METHODS: Targeted new-generation sequencing was used to identify TLR7 coding variants in 319 patients with juvenile-onset (j)SLE from the UK. Functional studies investigated molecular impacts associated with a previoulsy unreported gene variant in TLR7. RESULTS: The previously unreported private TLR7 coding variant p.Glu834* (heterozygous), introducing a stop codon, was identified in a female patient with jSLE with multisystemic disease and a family history of lupus-like autoimmunity and premature deaths. The patient was born preterm and exhibited neurodevelopmental delay and severe neuropsychiatric involvement. On the molecular level, TLR7 p.Glu834* is associated with sustained interaction with the UNC93B1 chaperone, allowing endolysosomal integration and noncanonical dimerisation with TLR8, resulting in enhanced proinflammatory cytokine expression following TLR7/8 engagement. In vitro observations were mirrored by an elevated IFN signature in peripheral blood cells from the patient. Molecular modelling indicated that formation of the TLR8:TLR7 p.Glu834* heterodimer is possible because of the shape complementarity of TLR7 and TLR8, and a more favourable interaction at the dimer interface for the TLR8:TLR7 p.Glu834* as compared with the endogenous TLR8:TLR8 dimer. CONCLUSIONS: Observations suggest that the private truncating TLR7 p.Glu834* variant associates with SLE-like clinical pictures through coupling with TLR8. Findings expand the list of SLE-associated disease mechanisms and support genetic risk stratification and consideration of TLR and/or IFN-targeted treatments.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Renaudineau Y, Hawkes J, Mizgalska K, et al. The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro. Ann Rheum Dis. 2026. PMID: 42632785. doi:10.1016/j.ard.2026.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。